Tomes, C., Rossi, S., & Moreno, S. Isobutylmethylxanthine and other classical cyclic nucleotide phosphodiesterase inhibitors affect cAMP-dependent protein kinase activity.
Cita Chicago Style (17a ed.)Tomes, C., S. Rossi, y S. Moreno. Isobutylmethylxanthine and Other Classical Cyclic Nucleotide Phosphodiesterase Inhibitors Affect CAMP-dependent Protein Kinase Activity.
Cita MLA (8a ed.)Tomes, C., et al. Isobutylmethylxanthine and Other Classical Cyclic Nucleotide Phosphodiesterase Inhibitors Affect CAMP-dependent Protein Kinase Activity.
Precaución: Estas citas no son 100% exactas.